Copyright
©The Author(s) 2024.
World J Diabetes. Sep 15, 2024; 15(9): 1903-1915
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1903
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1903
β, 95%CI | P value | |
Male vs female | 31.08 (9.81 to 52.36) | 0.0046 |
Age, per 1-year increase | -2.44 (-3.46 to -1.42) | < 0.0001 |
Education level | ||
Junior high school or below | Reference | |
Senior high school | -19.95 (-48.87 to 8.97) | 0.1778 |
College or above | 2.39 (-25.48 to 30.26) | 0.8666 |
SBP, per 1 mmHg increase | 0.42 (-0.11 to 0.95) | 0.1222 |
DBP, per 1 mmHg increase | 1.27 (0.26 to 2.27) | 0.0141 |
Height, per 1 cm increase | 1.74 (0.41 to 3.08) | 0.0111 |
Weight, per 1 cm increase | 1.17 (0.17 to 2.17) | 0.0234 |
BMI, per 1 kg/m2 increase | 1.96 (-1.63 to 5.55) | 0.2865 |
Duration of diabetes, per 1-year increase | -0.40 (-1.99 to 1.20) | 0.6269 |
Hypertension vs absent | -2.97 (-24.42 to 18.48) | 0.7862 |
Diabetic nephropathy history vs absent | 40.23 (13.83 to 66.64) | 0.0031 |
Stroke history vs absent | 2.07 (-46.41 to 50.55) | 0.9333 |
Anemia vs absent | 12.80 (-10.31 to 35.91) | 0.2788 |
Heart disease vs absent | -19.42 (-67.84 to 28.99) | 0.4325 |
PRP | ||
None | Reference | |
Partial | 4.02 (-24.99 to 33.03) | 0.7861 |
Whole | 31.00 (7.32 to 54.69) | 0.0109 |
Anti-VEGF therapy vs absent | 30.55 (6.24 to 54.86) | 0.0145 |
Insulin vs absent | 23.81 (2.63 to 44.99) | 0.0286 |
Oral glucose-lowering drugs vs absent | -28.96 (-53.31 to -4.62) | 0.0205 |
Calcium antagonists vs absent | 40.49 (14.86 to 66.13) | 0.0022 |
Visual acuity, per 1 LogMAR increase | -12.24 (-32.49 to 8.01) | 0.2374 |
IOP, per 1 mmHg increase | 2.27 (-0.32 to 4.86) | 0.0876 |
Fasting blood glucose, per 1 mmol/L increase | -2.34 (-6.06 to 1.39) | 0.2201 |
Serum urea nitrogen, per 1 mmol/L increase | 1.63 (-0.81 to 4.06) | 0.1910 |
Serum creatinine, per 1 μmol/L increase | 0.08 (0.02 to 0.14) | 0.0092 |
eGFR, per 1 mL/minutes × 1.73m2 increase | -0.15 (-0.50 to 0.20) | 0.3938 |
Uric acid, per 1 mmol/L | -0.01 (-0.14 to 0.11) | 0.8322 |
Triglyceride, per 1 mmol/L increase | -3.01 (-24.36 to 18.34) | 0.7828 |
Total cholesterol, per 1 mmol/L increase | -16.08 (-29.25 to -2.91) | 0.0181 |
HDL-C, per 1 mmol/L increase | -42.66 (-81.44 to -3.89) | 0.0329 |
LDL-C, per 1 mmol/L increase | -15.27 (-30.72 to 0.17) | 0.0548 |
HbA1c, per 1 % increase | -5.36 (-16.77 to 6.04) | 0.3590 |
CMT, per 1 μm increase | 0.02 (-0.06 to 0.11) | 0.5839 |
Ocular axial length, per 1 mm increase | -18.57 (-34.96 to -2.18) | 0.0282 |
- Citation: Lei CY, Xie JY, Ran QB, Zhang MX. Non-linear relationship between age and subfoveal choroidal thickness in Chinese patients with proliferative diabetic retinopathy. World J Diabetes 2024; 15(9): 1903-1915
- URL: https://www.wjgnet.com/1948-9358/full/v15/i9/1903.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i9.1903